- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01867723
Improving Symptom Management for Cancer Patients and Their Caregivers Through Internet
Improving Symptom Management for Cancer Patients and Their Caregivers Through Internet Support: A Randomized Clinical Trial
Being diagnosed and treated for cancer is usually associated with severe side effects and symptoms. Cancer patients can have difficulty to manage the symptoms as a result of treatment which may cause i) an interruption or cessation of cancer treatment ii) can have a negative impact on patients' quality of life (QoL). Family caregivers (FCs) of cancer patients are often the primary source of social and emotional support for patients, and play major roles in how well patients manage with the consequences of illness and treatment. Thus, FCs are clinically important, since supporting FCs indirectly supports patients.
To help both cancer patients and their FCs to manage their symptoms, our center has developed WebChoice now called Connect, an internet based support system that extends traditional health services into cancer patients' homes. Connect provides individualized symptom management support, illness relevant information, and communication with a clinical nurse specialist in cancer care, as well as with other cancer patients and their FCs over the Internet. The objectives of this interdisciplinary research project are to test main and interaction effects of providing Connect to patients, to FCs or both simultaneously on 1) primary patient outcomes in terms of symptom distress, QoL, depression, fatigue and sleep 2) Primary FC outcomes in terms of symptom distress, QoL, depression, fatigue, sleep and FC burden 3) Secondary, or intermediate, patient and FC outcomes in terms of self-efficacy social support, and self-reported health care utilization.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Cancer patients often experience multiple symptoms due to the illness itself and its treatment. Failure to detect and relieve patients' symptoms can have deleterious effects on patients [1]. To adequately help patients, it is important to understand how symptoms vary and co-vary during different phases of patients' illness trajectory. A major limitation in previous studies of symptoms in patients undergoing cancer treatment is that they have not evaluated symptom changes over time during and how changes in one or more symptom influence patients QoL. Furthermore, compelling evidence exist that cancer patients do not receive adequate symptom management or palliative care during the course of their illness [2-4].
A barrier to appropriate symptom management is the lack of interventions that support patients effectively in symptom management and self-management. Within the current health system, patients get limited help with their symptoms and health problems. This problem is accentuated by short hospital stays or consultations. Side-effects of treatment usually are at their worst after discharge from the hospital, and patients spend most of the time at home, leaving them with considerable symptom distress without much assistance. To overcome these problems, the Center for Shared Decision Making (CSDM) and Collaborative Care Research at Olso University Hospital (OUS) has developed WebChoice now called Connect, an Internet based support system that extends traditional health services into cancer patients' homes. Connect provides individualized symptom management support, illness relevant information, and communication with a clinical nurse specialist (CNS) in cancer care, as well as with other cancer patients over the Internet. v has been tested in an RCT funded by the Norwegian Cancer Society with breast and prostate cancer patients nationwide. Results from this RCT and other previous studies on Connect components demonstrate significant improvements in patient-centered care [5-7] and patient outcomes in terms of less symptom distress of depression. Also patients with access to WebChoice maintained self-efficacy and health related quality of life over time while the control group deteriorated significantly. (under review). Therefore, an important next step and aim of this study is to expand and test Connect in the following, to benefit a larger group of patients.
Research has repeatedly shown that FCs of cancer patients experience many problems, symptoms and burden [8]. However, the relationship between patient and FCs symptoms and problems is not yet sufficiently understood. Affecting one may also affect the other, and interventions that support FCs could also support patients and vice versa, reducing symptom distress [9]. Therefore, we will extend Connect to support cancer patients and their FCs, and test its effects on patient and FC outcomes.
Thus the specific aims for Phase II of this project are to:
1. Develop and test the effects of an extended Connect module to support (1) cancer patients and (2) their FCs on patient and FC outcomes.
Research Questions:
Following cancer patients and their FCs with 3 repeated measures over 6 months, this study will test main and interaction effects of providing Connect to patients, to FCs or both simultaneously on:
- Primary patient outcomes in terms of symptom distress, HRQoL, depression, fatigue and sleep.
- Primary FC outcomes in terms of symptom distress, QoL, depression, fatigue, sleep and care giver burden.
- Secondary, or intermediate, patient and FC outcomes in terms of self-efficacy, social support, and self-reported health care utilization.
- To better understand how these effects may occur, we will explore relationships between primary patient and FC outcomes; and how primary and secondary outcomes vary and co-vary across experimental conditions. Additional research questions are:
- How do patients and FCs use Connect? What is the frequency of use and which components are most used?
- What are patients' and FCs perceptions of usefulness and ease of use of Connect?
Study Type
Enrollment (Actual)
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
-
Oslo, Norway, 4950
- Oslo University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- diagnosed and treated for cancer;
- > 18 years of age,
- able to read/write/speak Norwegian,
- written informed consent, and
- have a FC who is willing to participate. FCs will be the individual the patient identifies as being most involved in their care.
Exclusion Criteria:
- Patients received cranial radiation or who have brain metastasis
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Internet communication application
Experiment 1 Effect of internet support program on cancer patients and their caregivers
|
Intervention 1 Effect of internet support program will be tested on cancer patients and their family caregivers No intervention
|
|
No Intervention: Control group
Control group get usual care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change from the Baseline in severity and duration of HRQoL
Time Frame: Baseline, 3 og 6 months
|
Baseline, 3 og 6 months
|
|
Change from the baseline in severity and duration of depression
Time Frame: Baseline, 3 and 6 months
|
Baseline, 3 and 6 months
|
|
Change from the Baseline in severity and duration of fatigue
Time Frame: Baseline, 3 and 6 months
|
Baseline, 3 and 6 months
|
|
Change from the baseline in severity and duration of sleep disorder
Time Frame: Baseline, 3 and 6 months
|
Baseline, 3 and 6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change from baseline in self-efficacy
Time Frame: Baseline and at 3 and 6 months
|
Baseline and at 3 and 6 months
|
|
Change from baseline in social support
Time Frame: Baseline, 3 and 6 months
|
Baseline, 3 and 6 months
|
|
Change from baseline in self-reported health care utilization
Time Frame: Baseline, 3 and 6 months
|
Baseline, 3 and 6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Cornelia Ruland, PHD, Oslo University Hospital- Raikshospitalet
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 6.2008.547
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fatigue
-
Bakulev Scientific Center of Cardiovascular SurgeryFoundation for the Support of Physical Culture and Sports BECOME A CHAMPION; Autonomous Non-Profit organization of additional education sports school BECOME A CHAMPIONRecruitingEfficacy, Self | Fatigue, Mental | Fatigue; Muscle, Heart | Fatigue; CombatRussian Federation
-
National Taiwan Sport UniversityGrape King Bio Ltd.CompletedEffect of Lactobacillus Plantarum GKK1 Supplementation on Anti-fatigue Health Effects (GKK1-Fatigue)Muscle Fatigue | Sports Performance | Exercise-Induced Fatigue | Fatigue RecoveryTaiwan
-
University of Southern MississippiEnrolling by invitationFatigue, Mental | Fatigue; Muscle, HeartUnited States
-
Universita di VeronaUniversity of Southern CaliforniaCompletedDiet, Healthy | Fasting | Fatigue, Mental | Fatigue; Muscle, HeartItaly
-
Akdeniz UniversityCompletedExercise-Induced Fatigue | Forearm Muscle FatigueTurkey (Türkiye)
-
Supplement Formulators, Inc.Completed
-
Tokat Gaziosmanpasa UniversityNot yet recruitingWork Engagement | Fatigue, Compassion | Quiet QuittingTurkey (Türkiye)
-
Istinye UniversityRecruitingMental Fatigue | Muscular FatigueTurkey (Türkiye)
-
Chengdu Sport UniversityNot yet recruiting
-
University of ZurichCompletedVocal FatigueSwitzerland
Clinical Trials on Internet communication application
-
Endocrine Research SocietyTerminated
-
University of Rhode IslandNortheastern University; Pro-Change Behavior SystemsCompletedSkin Cancer | SedentaryUnited States
-
University Health Network, TorontoNot yet recruitingSolid Organ Transplant | Liver Transplant | Kidney Transplant | Heart Transplant
-
Vanderbilt University Medical CenterRecruitingCritical Illness | Intensive Care MedicineUnited States
-
St. Joseph's Healthcare HamiltonMcMaster UniversityUnknownChronic Kidney DiseaseCanada
-
Ottawa Hospital Research InstituteCompletedElective Surgical ProceduresCanada
-
Seoul National University HospitalUnknownKidney TransplantationKorea, Republic of
-
University of VirginiaNational Institute of Mental Health (NIMH)WithdrawnPost-Traumatic Stress DisorderUnited States
-
Fundació Institut de Recerca de l'Hospital de la...Fundació La Marató de TV3CompletedAcute Respiratory Tract InfectionsSpain
-
University of Mogi das CruzesCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Instituto Federal...Completed